A Belgian court of the First Instance in Brussels started today, Wednesday the legal procedures against AstraZeneca, the Anglo-Swedish giant drugs maker.
The lawsuit related to the company's failure of supplying the contracted doses of its anti-Corona vaccine to the members of the European Union (EU) on time.
The European Commission, the executive body of the EU has launched litigating campaign of the company as it did not honor its contracts with the EU members along with the absence of an authorized plan to secure delivery of the vaccine in proper time to face the increase of infections in the EU.
The Commission issued a statement says that the trial of the Anglo-Swedish company will be public in two sessions.
Legal experts indicate the trial may run for several weeks.
For its part, the company announced its sorrow for the European trial and assured it will deliver 50 doses of the vaccine to the European countries by the end of April.
In another context, the Ministry of Health in Ukraine affirmed it has received more than three thousand complaints about the side effects of the anti-Corona vaccine used in the country.
The Center of Experts under the Ukrainian government issued a statement yesterday that said that the mechanic system had received 1045 notifications about the side effects of the vaccines since the inception of the campaign of vaccination weeks ago.
It is worth noting that more than 539 thousand people in Ukraine have been vaccinated.
In another context, the health authorities in Quebec, a French –spoken province in Canada, unveiled the first death resulted from thrombosis after receiving the anti-Corona vaccine produced by AstraZeneca.
The local Ministry of Health in the Canadian province indicated that a woman at the age of 54 died earlier in April after receiving a dose of AstraZeneca's vaccine.
Francois Lego, Premiere of Quebec extended condolence to the family of the deceased lady.
He pointed out that the benefits of the vaccine surpass its dangers.